Literature DB >> 14607964

Impaired germinal center maturation in adenosine deaminase deficiency.

Melissa B Aldrich1, Wilma Chen, Michael R Blackburn, Hector Martinez-Valdez, Surjit K Datta, Rodney E Kellems.   

Abstract

Mice deficient in the enzyme adenosine deaminase (ADA) have small lymphoid organs that contain reduced numbers of peripheral lymphocytes, and they are immunodeficient. We investigated B cell deficiency in ADA-deficient mice and found that B cell development in the bone marrow was normal. However, spleens were markedly smaller, their architecture was dramatically altered, and splenic B lymphocytes showed defects in proliferation and activation. ADA-deficient B cells exhibited a higher propensity to undergo B cell receptor-mediated apoptosis than their wild-type counterparts, suggesting that ADA plays a role in the survival of cells during Ag-dependent responses. In keeping with this finding, IgM production by extrafollicular plasmablast cells was higher in ADA-deficient than in wild-type mice, thus indicating that activated B cells accumulate extrafollicularly as a result of a poor or nonexistent germinal center formation. This hypothesis was subsequently confirmed by the profound loss of germinal center architecture. A comparison of levels of the ADA substrates, adenosine and 2'-deoxyadenosine, as well resulting dATP levels and S-adenosylhomocysteine hydrolase inhibition in bone marrow and spleen suggested that dATP accumulation in ADA-deficient spleens may be responsible for impaired B cell development. The altered splenic environment and signaling abnormalities may concurrently contribute to a block in B cell Ag-dependent maturation in ADA-deficient mouse spleens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607964     DOI: 10.4049/jimmunol.171.10.5562

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Restoring balance to B cells in ADA deficiency.

Authors:  Eline T Luning Prak
Journal:  J Clin Invest       Date:  2012-05-24       Impact factor: 14.808

2.  polyethylene glycol-conjugated adenosine deaminase (ADA) therapy provides temporary immune reconstitution to a child with delayed-onset ADA deficiency.

Authors:  Elke Lainka; Michael S Hershfield; Ines Santisteban; Pawan Bali; Annette Seibt; Jennifer Neubert; Wilhelm Friedrich; Tim Niehues
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

3.  Gut Microbial Metabolites Fuel Host Antibody Responses.

Authors:  Myunghoo Kim; Yaqing Qie; Jeongho Park; Chang H Kim
Journal:  Cell Host Microbe       Date:  2016-07-28       Impact factor: 21.023

4.  Tertiary lymphoid structures in the choroid plexus in neuropsychiatric lupus.

Authors:  Ariel D Stock; Evan Der; Sivan Gelb; Michelle Huang; Karen Weidenheim; Ayal Ben-Zvi; Chaim Putterman
Journal:  JCI Insight       Date:  2019-06-06

5.  Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activation.

Authors:  José M Martinez-Navio; Núria Climent; Rodrigo Pacheco; Felipe Garcia; Montserrat Plana; Meritxell Nomdedeu; Harold Oliva; Cristina Rovira; Laia Miralles; José M Gatell; Teresa Gallart; Josefa Mallol; Carme Lluis; Rafael Franco
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

6.  Assessment of adenosine deaminase (ADA) activity and oxidative stress in patients with chronic tonsillitis.

Authors:  Mehmet Fatih Garca; Halit Demir; Mahfuz Turan; Nazım Bozan; Ahmet Kozan; Şeyda Bayel Belli; Ayşe Arslan; Hakan Cankaya
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-12-04       Impact factor: 2.503

Review 7.  Inborn errors of the development of human natural killer cells.

Authors:  Emmanuelle Jouanguy; Laure Gineau; Julien Cottineau; Vivien Béziat; Eric Vivier; Jean-Laurent Casanova
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-12

8.  Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy.

Authors:  Aisha V Sauer; Henner Morbach; Immacolata Brigida; Yen-Shing Ng; Alessandro Aiuti; Eric Meffre
Journal:  J Clin Invest       Date:  2012-05-24       Impact factor: 14.808

9.  Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2.

Authors:  Daniel J Hodson; Arthur L Shaffer; Wenming Xiao; George W Wright; Roland Schmitz; James D Phelan; Yandan Yang; Daniel E Webster; Lixin Rui; Holger Kohlhammer; Masao Nakagawa; Thomas A Waldmann; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-18       Impact factor: 11.205

10.  Normal IgH Repertoire Diversity in an Infant with ADA Deficiency After Gene Therapy.

Authors:  Carolyn H Baloh; Samiksha A Borkar; Kai-Fen Chang; Jiqiang Yao; Michael S Hershfield; Suhag H Parikh; Donald B Kohn; Maureen M Goodenow; John W Sleasman; Li Yin
Journal:  J Clin Immunol       Date:  2021-06-28       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.